Serum marker predicts cardiovascular events in diabetes

April 25, 2014
Serum marker predicts cardiovascular events in diabetes

(HealthDay)—Elevated levels of polyclonal serum immunoglobulin combined free light chains (cFLCs) may indicate adverse cardiovascular disease (CVD) outcomes in patients with type 2 diabetes, according to research published online April 17 in Diabetes Care.

Srikanth Bellary, M.B.B.S., of Aston University in Birmingham, U.K., and colleagues conducted a of 352 South Asian patients with type 2 diabetes to assess the association between cFLCs and cardiovascular disease events.

The researchers found that, among patients with type 2 diabetes who had CVD events during two years of follow-up, cFLC levels were elevated in 8 percent (50.7 versus 42.8 mg/L; P = 0.004). According to , elevated cFLC level (greater than 57.2 mg/L) was associated with adverse CVD outcomes (odds ratio, 3.3; 95 percent confidence interval, 1.3 to 8.2; P = 0.012). This association remained significant after adjustment for age, albumin-to-creatinine ratio, diabetes duration, or treatment.

"cFLC elevation is a novel marker for CVD outcomes in type 2 diabetes that warrants further investigation," the authors write.

The United Kingdom Asian Diabetes Study and several study authors received funding from pharmaceutical companies.

Explore further: Poor health-related function, diabetes combo ups death risk

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Poor health-related function, diabetes combo ups death risk

March 30, 2012

(HealthDay) -- The combination of type 2 diabetes and impaired health-related functioning (HRF) is associated with an increased risk of cardiovascular disease (CVD) mortality, according to a study published online March 23 ...

Genetic predisposition to diabetes ups risk of CVD

October 23, 2012

(HealthDay)—For patients with type 2 diabetes (T2D), having a genetic predisposition towards the disease is associated with an increased risk of cardiovascular disease (CVD), according to a study published online Oct. 15 ...

Omega-3 fatty acids, xanthophylls don't cut CVD risk

March 21, 2014

(HealthDay)—Dietary supplementation with ω-3 polyunsaturated fatty acids or macular xanthophylls do not seem to reduce the risk of cardiovascular disease (CVD) in older adults with age-related macular degeneration, according ...

Health behavior change cuts CVD risk after T2DM diagnosis

March 31, 2014

(HealthDay)—For adults newly diagnosed with type 2 diabetes, adoption of healthy behavior changes is associated with reduced cardiovascular disease (CVD) risk, according to a study published online March 21 in Diabetes ...

Interarm BP difference may up cardiac risk in diabetes

April 3, 2014

(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published online on March ...

Nonalcoholic fatty liver disease linked to CKD in T1DM

April 9, 2014

(HealthDay)—For patients with type 1 diabetes, nonalcoholic fatty liver disease (NAFLD) is independently associated with the risk of incident chronic kidney disease (CKD), according to a study published online April 2 in ...

Recommended for you

Engineered hot fat implants reduce weight gain in mice

August 20, 2015

Scientists at the University of California, Berkeley, have developed a novel way to engineer the growth and expansion of energy-burning "good" fat, and then found that this fat helped reduce weight gain and lower blood glucose ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

Promising progress for new treatment of type 1 diabetes

July 30, 2015

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports, reveals that administration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.